Functional integration of microRNAs into oncogenic and tumor suppressor pathways.

Cell Cycle
Craig D LottermanJoshua T Mendell

Abstract

A large body of evidence has documented abnormal microRNA (miRNA) expression patterns in diverse human malignancies. Given that miRNA expression is tightly regulated during development and cellular differentiation, aberrant miRNA expression in cancer cells is likely to be in part a consequence of the loss of normal cellular identity that accompanies malignant transformation. Nevertheless, it is now clear that miRNAs function as critical effectors of several canonical oncogenic and tumor suppressor pathways, including those controlled by Myc and p53. Gain- and loss-of-function of these factors in cancer cells contributes to miRNA dysregulation, directly influencing neoplastic phenotypes including cellular proliferation and apoptosis.

Citations

Mar 6, 2009·Nature Reviews. Cancer·Milena S NicolosoGeorge A Calin
Jan 15, 2011·Seminars in Hematology·Katherine R CalvoIrene M Ghobrial
Jul 14, 2010·Cancer Genetics and Cytogenetics·Ye YangYun-Jie Wang
Apr 13, 2010·Experimental Cell Research·Lars-Gunnar Larsson, Marie Arsenian Henriksson
Dec 8, 2009·Current Opinion in Genetics & Development·Laura Soucek, Gerard I Evan
Sep 12, 2009·The EMBO Journal·Chin-Hsing LinRobert N Eisenman
Oct 15, 2010·The Prostate·Kati K WalteringTapio Visakorpi
Oct 3, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mohammad Hossein AnsariAmaneh Mohammadi Roushandeh
Dec 9, 2008·Cancer Cell·Brian W Freie, Robert N Eisenman
Jul 9, 2013·Toxicology·Damir SimicTerry Van Vleet
Oct 6, 2012·Molecular BioSystems·Chao-Shun Yang, Tariq M Rana
Sep 14, 2016·International Immunopharmacology·Mario VenzaIsabella Venza
May 31, 2018·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ana P Ferragut CardosoJ Christopher States
Jun 12, 2018·Journal of Pediatric Hematology/oncology·Çiğdem Ö EcevitNur Olgun
Aug 23, 2019·Wiley Interdisciplinary Reviews. RNA·Shama Prasada KabekkoduKapaettu Satyamoorthy
Jul 5, 2017·Genes, Chromosomes & Cancer·Martha L SlatteryRoger K Wolff
Oct 2, 2019·Cell Death & Disease·Saravanan GanesanVikram Mathews
Apr 9, 2016·Oncotarget·Zheng FanNicolai E Savaskan
Sep 5, 2020·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Tomasz KolendaKatarzyna Lamperska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Cell Cycle
Pedro P Medina, Frank J Slack
Annual Review of Cell and Developmental Biology
Carla GrandoriRobert N Eisenman
International Journal of Cancer. Journal International Du Cancer
Lin XiaDaiming Fan
Seminars in Cancer Biology
Chi V DangFeng Li
© 2022 Meta ULC. All rights reserved